Scribd Logo
Upload

Welcome to Scribd!

  • 61 views

    Use of Oral Antibiotics: High Risk Low Risk

    Uploaded by

    palak32
    This document provides guidelines for treating neutropenic patients with oral or intravenous antibiotics depending on their risk level and response to initial treatment. It recommends continuing or changing antibiotics based on whether an etiology is identified, clinical response over the first 3 days, and whether the patient is considered low or high risk based on defined criteria such as neutrophil count and temperature. The goal is to transition patients from intravenous to oral antibiotics when appropriate and discharge those who are clinically stable and responding to treatment.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOC, PDF, TXT or read online from Scribd

    Use of Oral Antibiotics: High Risk Low Risk

    Uploaded by

    palak32
    61 views1 page
    This document provides guidelines for treating neutropenic patients with oral or intravenous antibiotics depending on their risk level and response to initial treatment. It recommends continuing or changing antibiotics based on whether an etiology is identified, clinical response over the first 3 days, and whether the patient is considered low or high risk based on defined criteria such as neutrophil count and temperature. The goal is to transition patients from intravenous to oral antibiotics when appropriate and discharge those who are clinically stable and responding to treatment.

    Original Description:

    abx

    Original Title

    Oral Antibiotics

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    DOC, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    This document provides guidelines for treating neutropenic patients with oral or intravenous antibiotics depending on their risk level and response to initial treatment. It recommends continuing or changing antibiotics based on whether an etiology is identified, clinical response over the first 3 days, and whether the patient is considered low or high risk based on defined criteria such as neutrophil count and temperature. The goal is to transition patients from intravenous to oral antibiotics when appropriate and discharge those who are clinically stable and responding to treatment.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOC, PDF, TXT or read online from Scribd
    Download as doc, pdf, or txt
    61 views1 page

    Use of Oral Antibiotics: High Risk Low Risk

    Uploaded by

    palak32
    This document provides guidelines for treating neutropenic patients with oral or intravenous antibiotics depending on their risk level and response to initial treatment. It recommends continuing or changing antibiotics based on whether an etiology is identified, clinical response over the first 3 days, and whether the patient is considered low or high risk based on defined criteria such as neutrophil count and temperature. The goal is to transition patients from intravenous to oral antibiotics when appropriate and discharge those who are clinically stable and responding to treatment.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOC, PDF, TXT or read online from Scribd
    Download as doc, pdf, or txt
    You are on page 1of 1

    Use of oral antibiotics

    Afebrile within the first 3 days of treatment

    Etiology identified No aetiology identified

    Low risk*

    High risk**

    High risk**

    Low risk*

    Change to oral Ciprofloxacin 750 mg 12 hourly + Co-amoxiclav 625mg 8 Hourly

    Continue same antibiotics

    Adjust to most Appropriate parenteral Therapy

    Change to appropriate Oral therapy

    Discharge

    (*) = Clinically well, Absolute Neutrophil count and Monocyte>0.1 and expected to rise, Normal Chest X-ray, Near normal hepatic and renal function, Duration of neutropaenia<7 days, No hypotension, No IV line infection, Peak temperature<39 C, No neurological/mental changes, No abdominal pain or comorbidity complications. (**) = Absolute Neutrphil Count <0.1, mucositis; unstable signs. High dose chemotherapy Treat proven Staphylococcus aureus bacteraemia with at least 14 days of flucloxacillin to prevent metastatic infection

    Haematology/Oncology Antibiotic Protocol for Neutropenic Patients Page 1 of 16

    Approved by Medicines Management Committee on 10 th April 2003 Review Date 10th April 2005

    You might also like

    pFad - Phonifier reborn

    Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

    Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


    Alternative Proxies:

    Alternative Proxy

    pFad Proxy

    pFad v3 Proxy

    pFad v4 Proxy